153 related articles for article (PubMed ID: 20541775)
21. Human retinal pigment epithelial cell interleukin-8 and monocyte chemotactic protein-1 modulation by T-lymphocyte products.
Elner SG; Elner VM; Bian ZM; Lukacs NW; Kurtz RM; Strieter RM; Kunkel SL
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):446-55. PubMed ID: 9040478
[TBL] [Abstract][Full Text] [Related]
22. Effect of IFN-beta therapy on the frequency and function of CD4(+)CD25(+) regulatory T cells and Foxp3 gene expression in relapsing-remitting multiple sclerosis (RRMS): a preliminary study.
Namdar A; Nikbin B; Ghabaee M; Bayati A; Izad M
J Neuroimmunol; 2010 Jan; 218(1-2):120-4. PubMed ID: 19932513
[TBL] [Abstract][Full Text] [Related]
23. Interferon beta-1a induces tumor necrosis factor receptor 1 but decreases tumor necrosis factor receptor 2 leukocyte mRNA levels in relapsing-remitting multiple sclerosis.
Reuss R; Pohle S; Retzlaff K; Hemberger J; Oschmann P
Neuroimmunomodulation; 2009; 16(3):171-6. PubMed ID: 19246939
[TBL] [Abstract][Full Text] [Related]
24. Interferon-beta up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes: significance for treatment of multiple sclerosis.
Marckmann S; Wiesemann E; Hilse R; Trebst C; Stangel M; Windhagen A
Clin Exp Immunol; 2004 Dec; 138(3):499-506. PubMed ID: 15544628
[TBL] [Abstract][Full Text] [Related]
25. T cell lymphokine-induced secretion of cytokines by monocytes from patients with multiple sclerosis.
Maimone D; Reder AT; Gregory S
Cell Immunol; 1993 Jan; 146(1):96-106. PubMed ID: 8425234
[TBL] [Abstract][Full Text] [Related]
26. Dysregulated production of leukemia inhibitory factor in immune cells of relapsing remitting multiple sclerosis patients.
Levy YA; Mausner-Fainberg K; Vaknin-Dembinsky A; Amidror T; Regev K; Karni A
J Neuroimmunol; 2015 Jan; 278():85-9. PubMed ID: 25595256
[TBL] [Abstract][Full Text] [Related]
27. Tumor necrosis factor-alpha and interleukin-6 regulate secretion of brain-derived neurotrophic factor in human monocytes.
Schulte-Herbrüggen O; Nassenstein C; Lommatzsch M; Quarcoo D; Renz H; Braun A
J Neuroimmunol; 2005 Mar; 160(1-2):204-9. PubMed ID: 15710474
[TBL] [Abstract][Full Text] [Related]
28. Synergistic immunomodulatory effects of interferon-beta1b and the phosphodiesterase inhibitor pentoxifylline in patients with relapsing-remitting multiple sclerosis.
Weber F; Polak T; Günther A; Kubuschok B; Janovskaja J; Bitsch A; Poser S; Rieckmann P
Ann Neurol; 1998 Jul; 44(1):27-34. PubMed ID: 9667590
[TBL] [Abstract][Full Text] [Related]
29. Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b.
Ochi H; Feng-Jun M; Osoegawa M; Minohara M; Murai H; Taniwaki T; Kira J
J Neurol Sci; 2004 Jul; 222(1-2):65-73. PubMed ID: 15240198
[TBL] [Abstract][Full Text] [Related]
30. Induction of human monocyte IL-1 mRNA and secretion during anti-CD3 mitogenesis requires two distinct T cell-derived signals.
Landis RC; Friedman ML; Fisher RI; Ellis TM
J Immunol; 1991 Jan; 146(1):128-35. PubMed ID: 1824588
[TBL] [Abstract][Full Text] [Related]
31. Expression of TNF-alpha mRNA by peripheral blood mononuclear cells of multiple sclerosis patients treated with IFN-beta 1A.
Sarchielli P; Critelli A; Greco L; Sokola E; Floridi A; Gallai V
Cytokine; 2001 Jun; 14(5):294-8. PubMed ID: 11444910
[TBL] [Abstract][Full Text] [Related]
32. High and dysregulated secretion of epidermal growth factor from immune cells of patients with relapsing-remitting multiple sclerosis.
Levy YA; Fainberg KM; Amidror T; Regev K; Auriel E; Karni A
J Neuroimmunol; 2013 Apr; 257(1-2):82-9. PubMed ID: 23466131
[TBL] [Abstract][Full Text] [Related]
33. Multiple sclerosis-associated retroviral agent (MSRV)-stimulated cytokine production in patients with relapsing-remitting multiple sclerosis.
Saresella M; Rolland A; Marventano I; Cavarretta R; Caputo D; Marche P; Perron H; Clerici M
Mult Scler; 2009 Apr; 15(4):443-7. PubMed ID: 19251836
[TBL] [Abstract][Full Text] [Related]
34. Immunoglobulin-like transcript 3, an inhibitor of T cell activation, is reduced on blood monocytes during multiple sclerosis relapses and is induced by interferon beta-1b.
Jensen MA; Yanowitch RN; Reder AT; White DM; Arnason BG
Mult Scler; 2010 Jan; 16(1):30-8. PubMed ID: 20007427
[TBL] [Abstract][Full Text] [Related]
35. Decreases in interleukin-4 secretion by invariant CD4(-)CD8(-)V alpha 24J alpha Q T cells in peripheral blood of patientswith relapsing-remitting multiple sclerosis.
Gausling R; Trollmo C; Hafler DA
Clin Immunol; 2001 Jan; 98(1):11-7. PubMed ID: 11141321
[TBL] [Abstract][Full Text] [Related]
36. Immune cell BDNF secretion is associated with white matter volume in multiple sclerosis.
Weinstock-Guttman B; Zivadinov R; Tamaño-Blanco M; Abdelrahman N; Badgett D; Durfee J; Hussein S; Feichter J; Patrick K; Benedict R; Ramanathan M
J Neuroimmunol; 2007 Aug; 188(1-2):167-74. PubMed ID: 17602759
[TBL] [Abstract][Full Text] [Related]
37. Loss of epidermal growth factor regulation by cobalamin in multiple sclerosis.
Scalabrino G; Galimberti D; Mutti E; Scalabrini D; Veber D; De Riz M; Bamonti F; Capello E; Mancardi GL; Scarpini E
Brain Res; 2010 May; 1333():64-71. PubMed ID: 20347721
[TBL] [Abstract][Full Text] [Related]
38. Differential regulation of neurotrophin expression in basal forebrain astrocytes by neuronal signals.
Wu H; Friedman WJ; Dreyfus CF
J Neurosci Res; 2004 Apr; 76(1):76-85. PubMed ID: 15048931
[TBL] [Abstract][Full Text] [Related]
39. Clinical response to glatiramer acetate correlates with modulation of IFN-gamma and IL-4 expression in multiple sclerosis.
Valenzuela RM; Costello K; Chen M; Said A; Johnson KP; Dhib-Jalbut S
Mult Scler; 2007 Jul; 13(6):754-62. PubMed ID: 17613604
[TBL] [Abstract][Full Text] [Related]
40. Immune cell NT-3 expression is associated with brain atrophy in multiple sclerosis patients.
Kalinowska-Łyszczarz A; Pawlak MA; Michalak S; Paprzycki W; Losy J
J Neuroimmunol; 2011 Dec; 240-241():109-13. PubMed ID: 22036954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
